US 8900555
Insulin derivative formulations for pulmonary delivery
granted A61KA61K38/28A61K9/0073
Quick answer
US patent 8900555 (Insulin derivative formulations for pulmonary delivery) held by Nektar Therapeutics expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Nektar Therapeutics
- Grant date
- Tue Dec 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K38/28, A61K9/0073, A61P, A61P3/10